Literature DB >> 33932162

Sensory gating in tobacco-naïve cannabis users is unaffected by acute nicotine administration.

Ashley M Francis1, Andrea Parks2, Joëlle Choueiry3,4, Nicole El-Marj5, Danielle Impey4,5, Verner J Knott2,3,4,5, Derek J Fisher6,7,8.   

Abstract

OBJECTIVES: Long-term cannabis use has been associated with the appearance of psychotic symptoms and schizophrenia-like cognitive impairments; however these studies may be confounded by concomitant use of tobacco by cannabis users. We aimed to determine if previously observed cannabis-associated deficits in sensory gating would be seen in cannabis users with no history of tobacco use, as evidenced by changes in the P50, N100, and P200 event-related potentials. A secondary objective of this study was to examine the effects of acute nicotine administration on cannabis users with no tobacco use history.
METHODS: Three components (P50, N100, P200) of the mid-latency auditory-evoked response (MLAER) were elicited by a paired-stimulus paradigm in 43 healthy, non-tobacco smoking male volunteers between the ages of 18-30. Cannabis users (CU, n = 20) were administered nicotine (6 mg) and placebo gum within a randomized, double-blind design. Non-cannabis users (NU, n = 23) did not receive nicotine.
RESULTS: Between-group sensory gating effects were only observed for the N100, with CUs exhibiting a smaller N100 to S1 of the paired stimulus paradigm, in addition to reduced dN100 (indicating poorer gating). Results revealed no significant sensory gating differences with acute administration of nicotine compared to placebo cannabis conditions.
CONCLUSIONS: These findings suggest a relationship between gating impairment and cannabis use; however, acute nicotine administration nicotine does not appear to impact sensory gating function.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Event-related potential; MLAEP; Marijuana; Mid-latency auditory-evoked potential; Nicotine; P50

Mesh:

Substances:

Year:  2021        PMID: 33932162     DOI: 10.1007/s00213-021-05843-6

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  54 in total

1.  Response to the first stimulus determines reduced auditory evoked response suppression in schizophrenia: single trials analysis using MEG.

Authors:  L D Blumenfeld; B A Clementz
Journal:  Clin Neurophysiol       Date:  2001-09       Impact factor: 3.708

2.  Midlatency evoked potentials attenuation and augmentation reflect different aspects of sensory gating.

Authors:  N N Boutros; A Belger
Journal:  Biol Psychiatry       Date:  1999-04-01       Impact factor: 13.382

3.  Genetic and environmental influences on sensory gating of mid-latency auditory evoked responses: a twin study.

Authors:  Andrey P Anokhin; Andrei B Vedeniapin; Andrew C Heath; Oleg Korzyukov; Nashaat N Boutros
Journal:  Schizophr Res       Date:  2006-10-02       Impact factor: 4.939

4.  Heterogeneity in the composition of marijuana seized in California.

Authors:  James Richard Burgdorf; Beau Kilmer; Rosalie Liccardo Pacula
Journal:  Drug Alcohol Depend       Date:  2011-02-01       Impact factor: 4.492

5.  Chronic effects of cannabis on sensory gating.

Authors:  Samantha J Broyd; Lisa-Marie Greenwood; Rodney J Croft; Anna Dalecki; Juanita Todd; Patricia T Michie; Stuart J Johnstone; Nadia Solowij
Journal:  Int J Psychophysiol       Date:  2013-04-28       Impact factor: 2.997

6.  Marijuana withdrawal among adults seeking treatment for marijuana dependence.

Authors:  A J Budney; P L Novy; J R Hughes
Journal:  Addiction       Date:  1999-09       Impact factor: 6.526

7.  Preattentional and attentional cognitive deficits as targets for treating schizophrenia.

Authors:  David L Braff; Gregory A Light
Journal:  Psychopharmacology (Berl)       Date:  2004-04-30       Impact factor: 4.530

8.  Normalization of auditory physiology by cigarette smoking in schizophrenic patients.

Authors:  L E Adler; L D Hoffer; A Wiser; R Freedman
Journal:  Am J Psychiatry       Date:  1993-12       Impact factor: 18.112

9.  Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics.

Authors:  L E Adler; L J Hoffer; J Griffith; M C Waldo; R Freedman
Journal:  Biol Psychiatry       Date:  1992-10-01       Impact factor: 13.382

10.  Sensory gating deficits during the mid-latency phase of information processing in medicated schizophrenia patients.

Authors:  Nashaat N Boutros; Oleg Korzyukov; Ben Jansen; Alan Feingold; Morris Bell
Journal:  Psychiatry Res       Date:  2004-05-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.